PD52-06TESTOSTERONE THERAPY IN WOMEN IS NOT ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK—A US CLAIMS DATABASE ANALYSISdoi:10.1097/01.JU.0001009412.04863.1b.06Jessica Y. HsuehPranjal AgrawalSajya M. SinghJaden KohnMarisa CliftonTaylor KohnWolters KluwerThe Journal of Urology...
In postmenopausal women, estrogen levels plummet while the ovaries continue to produce testosterone, the researchers point out. "There has been so much focus on estrogen being protective, but it may be that testosterone is toxic," which might explain why men get heart disease earlier than women,...
The goal of testosterone restoration in most cases is to restore youthful blood levels of the hormone. Typically, Life Extension suggests men target a blood level of testosterone between700and900 ng/dLfor optimal health. In studies designed to assess the impact of t...
Testosterone is the main male sex hormone and is essential for the maintenance of male secondary sexual characteristics and fertility. Androgen deficiency in young men owing to organic disease of the hypothalamus, pituitary gland or testes has been treat
Testosterone Supplementation Therapy for Older Men: Potential Benefits and Risks Serum testosterone levels decline gradually and progressively with aging in men. Many manifestations associated with aging in men, including muscle atrophy... D Gruenewald - 《Journal of the American Geriatrics Society》 被...
A recentCosmos Study, published by Epic Research on January 16, 2024, revealed that men with low testosterone who are being treated with testosterone replacement therapy (TRT) have an increased risk of cardiovascular disease (CVD) compared to those who are not on TRT. ...
(2005), Testosterone replacement therapy in hypogonadal men and prostate cancer risk. BJU International, 96: 471–472. doi: 10.1111/j.1464-410X.2005.05665.x Author Information Department of Urology, St George's Hospital, London, UK *Duncan Gould, 20 Harmont House, 20 Harley Street, London, ...
Changes in the levels of circulating proteins are associated with Alzheimer’s disease (AD), whereas their pathogenic roles in AD are unclear. Here, we identified soluble ST2 (sST2), a decoy receptor of interleukin-33–ST2 signaling, as a new disease-causing factor in AD. Increased circulating...
Fournier JP, Duijnhoven RG, Renoux C, Dell’Aniello S, Klungel OH, Suissa S. Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study. Menopause. 2014;21(9):1023-1026. doi:10.109...
The analyses show that testosterone therapy was not associated with an increased risk of heart attack. Further, testosterone users with a higher probability of cardiovascular problems had a lower rate of heart attacks in comparison to equivalent patients who did not receive testosterone therapy. ...